Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus

References

• Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int. 2004;66:1310–1314. doi:10.1111/j.1523-1755.2004.00894.x
   PubMed Web of Science ®Google Scholar
• Yano Y, Fujimoto S, Asahi K, Watanabe T. Prevalence of chronic kidney disease in China. Lancet. 2012;380:214. doi:10.1016/S0140-6736(12)61209-4
   Google Scholar
• Chingha KB, Beddhu S. Metabolic syndrome and chronic kidney disease. Minerva Urol Nefrol. 2006;58:1–12.
   PubMedGoogle Scholar
• Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet. 1998;352:213–219. doi:10.1016/S0140-6736(98)01346-4
   PubMed Web of Science ®Google Scholar
• Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 Patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong diabetes registry. Diabetes Care. 2008;31:2357–2361. doi:10.2337/dc08-0971
   PubMed Web of Science ®Google Scholar
• Fan F, Qi L, Jia J, et al. Noninvasive central systolic blood pressure is more strongly related to kidney function decline than peripheral systolic blood pressure in a Chinese community-based population. Hypertension. 2016;67:1166–1172. doi:10.1161/HYPERTENSIONAHA.115.07019
   PubMed Web of Science ®Google Scholar
• Othman M, Kawar B, Elnahas AM. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract. 2009;113:c16–c23. doi:10.1159/000228071
   PubMedGoogle Scholar
• Rodenbach KE, Schneider MF, Furth SL, et al. Hyperuricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKiD) cohort study. Am J Kidney Dis. 2015;66:984–992. doi:10.1053/j.ajkd.2015.06.015
   PubMed Web of Science ®Google Scholar
• Ferrannini E. Insulin resistance, iron, and the liver. Lancet. 2000;355:2181–2182. doi:10.1016/S0140-6736(00)02397-7
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, Crandall JP, Wylierosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta. 2009;1790:671–681. doi:10.1016/j.bbagen.2008.04.005
   PubMed Web of Science ®Google Scholar
• Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, Torti FM. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol. 2000;20:5818–5827. doi:10.1128/MCB.20.16.5818-5827.2000
   PubMed Web of Science ®Google Scholar
• Kang HT, Linton JA, Kwon SK, Park BJ, Lee JH. Ferritin level is positively associated with chronic kidney disease in Korean men, based on the 2010–2012 Korean National Health and Nutrition Examination Survey. Int J Environ Res Public Health. 2016;13:1058. doi:10.3390/ijerph13111058
   PubMedGoogle Scholar
• Chen T, Ren Y, Gao Y, Tian H. Serum gamma-glutamyl transferase and ferritin synergistically associated with the rate of chronic kidney disease. Dis Markers. 2017;2017:9765259. doi:10.1155/2017/9765259
   PubMed Web of Science ®Google Scholar
• Leung PS, Srai SK, Mascarenhas M, Churchill LJ, Debnam ES. Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression. Gut. 2005;54:1391–1395. doi:10.1136/gut.2004.062083
   PubMed Web of Science ®Google Scholar
• Gassmann M, Muckenthaler MU. Adaptation of iron requirement to hypoxic conditions at high altitude. J Appl Physiol (1985). 2015;119:1432–1440. doi:10.1152/japplphysiol.00248.2015
   PubMedGoogle Scholar
• Papanikolaou G, Pantopoulos K. Systemic iron homeostasis and erythropoiesis. IUBMB Life. 2017;69:399–413. doi:10.1002/iub.v69.6
   PubMed Web of Science ®Google Scholar
• Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67:2089–2100. doi:10.1111/j.1523-1755.2005.00365.x
   PubMed Web of Science ®Google Scholar
• Su HM, Tsai WC, Lin TH, et al. P wave dispersion and maximum P wave duration are independently associated with rapid renal function decline. PLoS One. 2012;7:e42815. doi:10.1371/journal.pone.0042815
   PubMed Web of Science ®Google Scholar
• Krolewski AS, Skupien J, Rossing P, et al. Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017;91:1300–1311. doi:10.1016/j.kint.2016.10.046
   PubMed Web of Science ®Google Scholar
• Piperno A. Classification and diagnosis of iron overload. Haematologica. 1998;83:447–455.
   PubMed Web of Science ®Google Scholar
• Deugnier Y, Bardou-Jacquet E, Laine F. Dysmetabolic iron overload syndrome (DIOS). Presse Med. 2017;46:e306–e311. doi:10.1016/j.lpm.2017.05.036
   PubMedGoogle Scholar
• Buren PV, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol. 2012;44:499–507. doi:10.1007/s11255-011-0028-5
   PubMedGoogle Scholar
• Hojs R, Ekart R, Bevc S, Hojs N. Markers of inflammation and oxidative stress in the development and progression of renal disease in diabetic patients. Nephron. 2016;133:159–162. doi:10.1159/000447434
   PubMedGoogle Scholar
• Cachofeiro V, Goicochea M, de Vinuesa SG, Oubiña P, Lahera V, Luño J. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl. 2008;74:S4–S9. doi:10.1038/ki.2008.516
   Web of Science ®Google Scholar
• Radcliffe NJ, Seah JM, Clarke M, Macisaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig. 2017;8:6–18. doi:10.1111/jdi.12533
   PubMed Web of Science ®Google Scholar
• Marathe PH, Gao HX, Close KL. American Diabetes Association standards of medical care in diabetes 2017. J Diabetes. 2017;9:320–324. doi:10.1111/1753-0407.12524
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:8–15. doi:10.1161/01.CIR.79.1.8
   PubMed Web of Science ®Google Scholar
• Ruilope LM, van Veldhuisen DJ, Ritz E, Luscher TF. Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol. 2001;38:1782–1787. doi:10.1016/S0735-1097(01)01627-8
   PubMed Web of Science ®Google Scholar
• Salinerofort MA, San Andrés-Rebollo FJ, de Burgos-lunar C, et al. Five-year incidence of chronic kidney disease (Stage 3–5) and associated risk factors in a Spanish cohort: the MADIABETES Study. PLoS One. 2015;10:e0122030. doi:10.1371/journal.pone.0122030
   PubMedGoogle Scholar